QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:QPS Austria GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10804
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them for drug testing projects. Its in vitro services provides various standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, central nervous system neurons of developmental stages and organotypic brain slices. QPS’s offers drug development services for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, schizophrenia, amyotrophic lateral sclerosis, and others. The company offers histological services ranging from collection of tissue samples to delivering study reports. QPS is headquartered in Grambach, Austria.

QPS Austria GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QPS Austria GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QPS Austria GmbH, Medical Devices Deals, 2012 to YTD 2018 9
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
Licensing Agreements 12
QPS Austria Enters into Licensing Agreement with Probiodrug 12
Acquisition 13
QPS Acquires Majority Stake In JSW Lifesciences 13
QPS Austria GmbH – Key Competitors 14
QPS Austria GmbH – Key Employees 15
QPS Austria GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
QPS Austria GmbH, Pharmaceuticals & Healthcare, Key Facts 2
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QPS Austria GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QPS Austria GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
QPS Austria GmbH, Medical Devices Deals, 2012 to YTD 2018 9
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
QPS Austria Enters into Licensing Agreement with Probiodrug 12
QPS Acquires Majority Stake In JSW Lifesciences 13
QPS Austria GmbH, Key Competitors 14
QPS Austria GmbH, Key Employees 15

List of Figures
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QPS Austria GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QPS Austria GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Swelect Energy Systems Ltd (SWELECTES):企業の財務・戦略的SWOT分析
    Summary Swelect Energy Systems Ltd (SESL), formerly Numeric Power Systems Ltd is an energy company that manufactures and markets renewable energy products and iron and steel products. The company’s renewable energy products include solar pv modules, solar inverter, solar water pump and energy effici …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Genzyme Corp:企業の戦略的SWOT分析
    Genzyme Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Shinsung Solar Energy Co.,Ltd. (011930):企業の財務及び戦略的SWOT分析
    Shinsung Solar Energy Co.,Ltd. (011930) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Tav Havalimanlari Holding A.S.:企業概要・SWOT・財務分析
    Summary Canadean's "Tav Havalimanlari Holding A.S. : Travel and Tourism - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, busines …
  • President Rice Products PCL:企業の戦略・SWOT・財務分析
    SummaryPresident Rice Products PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Innate Pharma SA (IPH):企業概要、財務及び戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a bio-pharmaceutical company. It holds expertise in the areas of immunopharmacology and antibody technology. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops …
  • Enea AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Enea AB Mergers and Acquisition …
  • Vanda Pharmaceuticals Inc (VNDA):製薬・医療:M&Aディール及び事業提携情報
    Summary Vanda Pharmaceuticals Inc (Vanda Pharmaceuticals) is a specialty pharmaceutical company that develops and commercializesnovel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour …
  • Kimoto Co., Ltd. (7908):企業財務及び戦略的SWOT分析
    Summary Kimoto Co., Ltd. (Kimoto) is an electronic equipment company that provides functional films for electronic devices. The company designs, develops, manufactures and distributes functional films and accessories. Its products include light diffusion and light reflection films; scratch resistant …
  • ITO EN Ltd:企業の戦略・SWOT・財務分析
    ITO EN Ltd - Strategy, SWOT and Corporate Finance Report Summary ITO EN Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • BizFlow Corporation:企業の戦略的SWOT分析
    BizFlow Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Transat A.T. Inc:企業の戦略・SWOT・財務情報
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • BioMedomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube base …
  • Building Energy SpA:石油・ガス:M&Aディール及び事業提携情報
    Summary Building Energy SpA (Building Energy) is a renewable energy company that operates and develops renewable energy projects such as biomass, hydro, wind and solar projects. The company provides operation and maintenance services such as real time performance monitoring, performance guarantee, p …
  • Boingo Wireless, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Boingo Wireless, Inc. Mergers a …
  • Concurrent Technologies Corporation:企業の戦略・SWOT・財務分析
    SummaryConcurrent Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • ALS Limited (ALQ):企業のM&A・提携動向(石油・ガス分野)
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides chemical and laboratory services, technical testing and inspection services supp …
  • Eidai Kako Co., Ltd. (7877):企業の財務及び戦略的SWOT分析
    Summary Eidai Kako Co., Ltd. (EIDAI) is a chemical company that manufactures synthetic resin products. The company manufactures and sells synthetic resin sheets and other products. It operates through business lines such as manufacture and sale of synthetic resin sheet; manufacture and sales of synt …
  • Hitachi Medical Systems America Inc:企業のM&A・提携動向(医療機器分野)
    Summary Hitachi Medical Systems America Inc (Hitachi Medical), a subsidiary of Hitachi Medical Corporation is a medical device company that develops, manufactures and markets x-ray equipments. The company offers MRI, CT, ultrasound, optical topography and x-ray equipments. Its services comprise cons …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆